Back
Denali Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
DNLI
Denali Therapeutics, Inc.
Last Price:
$20.65
Seasonality Move:
11.38%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Denali Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.87 | Buy |
| 20-day SMA: | 20.33 | Buy |
| 50-day SMA: | 20.52 | Buy |
| 200-day SMA: | 16.91 | Buy |
| 8-day EMA: | 19.84 | Buy |
| 20-day EMA: | 20.11 | Buy |
| 50-day EMA: | 19.94 | Buy |
| 200-day EMA: | 18.23 | Buy |
Denali Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 52.54 | Buy |
| Chaikin Money Flow: | 1606875 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.38 - 21.34) | Buy |
| Bollinger Bands (100): | (17.29 - 20.87) | Buy |
Denali Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics, Inc. Stock
Is Denali Therapeutics, Inc. Stock a Buy?
-
Denali Therapeutics, Inc. share price is 20.65 while DNLI 8-day simple moving average is 19.87, which is a Buy signal.
-
The stock price of DNLI is 20.65 while Denali Therapeutics, Inc. 20-day SMA is 20.33, which makes it a Buy.
-
Denali Therapeutics, Inc. 50-day simple moving average is 20.52 while DNLI share price is 20.65, making it a Buy technically.
-
DNLI stock price is 20.65 and Denali Therapeutics, Inc. 200-day simple moving average is 16.91, creating a Buy signal.
DNLI Technical Analysis vs Fundamental Analysis
Buy
52
Denali Therapeutics, Inc. (DNLI)
is a Buy
Is Denali Therapeutics, Inc. a Buy or a Sell?
-
Denali Therapeutics, Inc. stock is rated a BuyThe current Denali Therapeutics, Inc. [DNLI] share price is $20.65. The Score for DNLI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Denali Therapeutics, Inc. Stock Info
Market Cap:
3.4B
Price in USD:
20.65
Share Volume:
1.6M
Denali Therapeutics, Inc. 52-Week Range
52-Week High:
23.77
52-Week Low:
10.57
Buy
52
Denali Therapeutics, Inc. (DNLI)
is a Buy
Denali Therapeutics, Inc. Share Price Forecast
-
What is the Denali Therapeutics, Inc. stock price today?The Denali Therapeutics, Inc. stock price is 20.65 USD today.
-
Will DNLI stock go up or go down?Denali Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Denali Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics, Inc. is not overvalued.
Is Denali Therapeutics, Inc. Stock a Buy?
-
Denali Therapeutics, Inc. share price is 20.65 while DNLI 8-day exponential moving average is 19.84, which is a Buy signal.
-
The stock price of DNLI is 20.65 while Denali Therapeutics, Inc. 20-day EMA is 20.11, which makes it a Buy.
-
Denali Therapeutics, Inc. 50-day exponential moving average is 19.94 while DNLI share price is 20.65, making it a Buy technically.
-
DNLI stock price is 20.65 and Denali Therapeutics, Inc. 200-day simple moving average is 18.23, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics, Inc.
Is Denali Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.10 per share, an increase this year of $0.52 per share, and an increase next year of $0.03 per share.
Technical Analysis of Denali Therapeutics, Inc.
Should I short Denali Therapeutics, Inc. stock?
-
DNLI Moving Average Covergence Divergence (MACD) indicator is -0.2, suggesting Denali Therapeutics, Inc. is a Sell
-
Denali Therapeutics, Inc. Relative Strength Index (RSI) is 52.54, which suggest Denali Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Denali Therapeutics, Inc. is (19.38 - 21.34), which suggest Denali Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Denali Therapeutics, Inc. is (17.29 - 20.87), which suggest Denali Therapeutics, Inc. is a Buy
* Denali Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.